Mirapex Buyers Bid For Class Status In Antitrust Case

Law360, New York (November 6, 2009, 2:13 PM EST) -- A group of paying customers has banded together in a newly amended complaint to accuse Boehringer Ingelheim International GmbH of prosecuting a patent it knew to be invalid in order to stymie generic-drug makers in their efforts to get cheaper versions of the Parkinson's drug Mirapex to market.

The putative class action, lodged Thursday in the U.S. District Court for the Western District of Pennsylvania, was filed two days after Judge Gary L. Lancaster gave the go-ahead with a case management order that calls for a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.